RE:Classic Bruce LintonI am not sure if the link to the transcribed Canopy investors call today has been put up here yet. It clearly outlines the steps taken to be ready for the opening day of legalization and the formidable expense in that endeavour.
Please be aware that with Canopoy's financial reporting this last quarter is referred to as Q4 2018 and references to sales growth in Q1 & Q2 2019 refer to June to December 2018 not 2019 proper.
One also has to wonder how much sales growth people really expected for this last quarter from medical sales only at this point?
I believe the big investors understand the up front pre legalization start up costs expenses issue and are not bothered by it one bit. However if they can use this to spin out the share price to their buying advantage they are going to feed like sharks.
Here is the transcribed investor's call from today:
https://seekingalpha.com/article/4184361-canopy-growth-corporation-cgc-ceo-bruce-linton-q4-2018-results-earnings-call-transcript?page=4